Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03500536 · ClinicalTrials.gov registry record · NA

Understanding the Efficacy of Mobile Apps as Intervention for Depression in Adults When Deployed as Part of Primary Care.

A NA study of Depression and Anxiety, sponsored by Actualize Therapy.

Completed
Registry status
NA
Development phase
146
Enrollment target
1
Study location

NCT03500536: Completed NA study of Depression and Anxiety, sponsored by Actualize Therapy.

NCT03500536 is a NA study of Depression and Anxiety that has completed, run by Actualize Therapy. The registered enrollment target is 146 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03500536, a NA study of Depression and Anxiety, has completed, sponsored by Actualize Therapy.

COMPLETED
Registry status
NA
Development phase
146 participants
Enrollment target
1
Study location

Study Summary

The clinical study is meant to optimize the mobile intervention, to develop a robust implementation plan for the mobile intervention within primary care, and to conduct an effectiveness trial, randomizing 128 participants in order to understand effect on severity of depression and anxiety symptoms, cost-effectiveness, and usability of mobile apps.

Primary Outcome

Using the PHQ-9 screener

Interventions

  • BEHAVIORAL IntelliCare

Study Locations (1)

Arkansas

  • University of Arkansas for Medical Sciences - Little Rock

Trial Details

FieldValue
Enrollment Target 146 participants
Start Date 2018-07-18
Est. Completion 2019-04-04
Phase NA
Actualize Therapy

1 total trials

What the finished NCT03500536 record still lists

NCT03500536 is an interventional study that assigns participants to a tested intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (81% lower).

The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which IntelliCare is the first listed.

NCT03500536 reports a single indexed study location in Arkansas.

Frequently Asked Questions

What is clinical trial NCT03500536 about?

NCT03500536 is a clinical study titled "Understanding the Efficacy of Mobile Apps as Intervention for Depression in Adults When Deployed as Part of Primary Care.". The clinical study is meant to optimize the mobile intervention, to develop a robust implementation plan for the mobile intervention within primary care, and to conduct an effectiveness trial, randomizing 128 participants in order to understand effect on severity of depression and anxiety symptoms, ...

What is the current status of trial NCT03500536?

This trial is currently completed. It is a NA study. The enrollment target is 146 participants. The study started on 2018-07-18. Estimated completion is 2019-04-04.

What conditions does trial NCT03500536 study?

This clinical trial studies the following conditions: Depression, Anxiety, Primary Health Care.

What interventions are being tested in trial NCT03500536?

The interventions under investigation include: IntelliCare (BEHAVIORAL).

Who is sponsoring clinical trial NCT03500536?

This trial is sponsored by Actualize Therapy, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03500536 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03500536's enrollment target sits among peer trials

146 265th of 679 higher than 414 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03490929 · 146 participants · Phase 4

    CEUS for Blunt Abdominal Trauma in Children

  • NCT04755062 · 146 participants · NA

    A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans

  • NCT04867954 · 146 participants

    Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis

  • NCT05051618 · 146 participants · NA

    Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT03500536, the US trial registry maintained by the National Library of Medicine. NCT03500536 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.